These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25630648)

  • 1. OXY-2-15, a novel variant showing increased ceftazidime hydrolytic activity.
    Nijhuis RH; Oueslati S; Zhou K; Bosboom RW; Rossen JW; Naas T
    J Antimicrob Chemother; 2015 May; 70(5):1429-33. PubMed ID: 25630648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevalence of extended-spectrum beta-lactamases in nosocomial Escherichia coli and Klebsiella spp. strains isolated from blood cultures].
    Zarakolu P; Metan G; Hasçelik G; Akova M
    Mikrobiyol Bul; 2007 Oct; 41(4):579-84. PubMed ID: 18173077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo selection of a chromosomally encoded beta-lactamase variant conferring ceftazidime resistance in Klebsiella oxytoca.
    Mammeri H; Poirel L; Nordmann P
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3739-42. PubMed ID: 14638475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Piperacillin/Tazobactam-Resistant Klebsiella oxytoca Recovered from a Nosocomial Outbreak.
    Fujita A; Kimura K; Yokoyama S; Jin W; Wachino J; Yamada K; Suematsu H; Yamagishi Y; Mikamo H; Arakawa Y
    PLoS One; 2015; 10(11):e0142366. PubMed ID: 26539828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phylogenetic lineages, clones and β-lactamases in an international collection of Klebsiella oxytoca isolates non-susceptible to expanded-spectrum cephalosporins.
    Izdebski R; Fiett J; Urbanowicz P; Baraniak A; Derde LP; Bonten MJ; Carmeli Y; Goossens H; Hryniewicz W; Brun-Buisson C; Brisse S; Gniadkowski M; ;
    J Antimicrob Chemother; 2015 Dec; 70(12):3230-7. PubMed ID: 26318191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel ceftazidime-hydrolysing extended-spectrum beta-lactamase, CTX-M-54, with a single amino acid substitution at position 167 in the omega loop.
    Bae IK; Lee BH; Hwang HY; Jeong SH; Hong SG; Chang CL; Kwak HS; Kim HJ; Youn H
    J Antimicrob Chemother; 2006 Aug; 58(2):315-9. PubMed ID: 16785225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of IMP-4 metallo-beta-lactamase production and porin deficiency causes carbapenem resistance in a Klebsiella oxytoca clinical isolate.
    Chen LR; Zhou HW; Cai JC; Zhang R; Chen GX
    Diagn Microbiol Infect Dis; 2009 Oct; 65(2):163-7. PubMed ID: 19748427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six groups of the OXY beta-Lactamase evolved over millions of years in Klebsiella oxytoca.
    Fevre C; Jbel M; Passet V; Weill FX; Grimont PA; Brisse S
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3453-62. PubMed ID: 16048960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First report of a novel extended-spectrum beta-lactamase KOXY-2 producing Klebsiella oxytoca that hydrolyses cefotaxime and ceftazidime.
    Younes A; Hamouda A; Amyes SG
    J Chemother; 2011 Jun; 23(3):127-30. PubMed ID: 21742579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, molecular characterization, and phenotypic confirmation of extended-spectrum beta-lactamases in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca at the Radboud University Nijmegen Medical Centre in The Netherlands.
    Sturm PD; Bochum ET; van Mook-Vermulst SV; Handgraaf C; Klaassen T; Melchers WJ
    Microb Drug Resist; 2010 Mar; 16(1):55-60. PubMed ID: 20001741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of an IncA/C plasmid encoding VIM-4 and CMY-4 β-lactamases in Klebsiella oxytoca and Citrobacter koseri from an inpatient in a cardiac rehabilitation unit.
    Caltagirone M; Bitar I; Piazza A; Spalla M; Nucleo E; Navarra A; Migliavacca R
    New Microbiol; 2015 Jul; 38(3):387-92. PubMed ID: 26147151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of plasmid-mediated multidrug resistance in Escherichia coli and Klebsiella oxytoca isolates from clinical specimens in Japan.
    Ode T; Saito R; Kumita W; Sato K; Okugawa S; Moriya K; Koike K; Okamura N
    Int J Antimicrob Agents; 2009 Oct; 34(4):347-50. PubMed ID: 19560903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftazidime-resistant Klebsiella oxytoca producing an OXY-2-type variant from Switzerland.
    Rodríguez-Martínez JM; Poirel L; Nordmann P; Fankhauser C; Francois P; Schrenzel J
    Int J Antimicrob Agents; 2008 Sep; 32(3):278-9. PubMed ID: 18602252
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanism of resistance and antibacterial susceptibility in extended-spectrum β-lactamase phenotype Klebsiella pneumoniae and Klebsiella oxytoca isolated between 2000 and 2010 in Japan.
    Sato T; Hara T; Horiyama T; Kanazawa S; Yamaguchi T; Maki H
    J Med Microbiol; 2015 May; 64(Pt 5):538-543. PubMed ID: 25813819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a novel IMP-28 metallo-β-lactamase from a Spanish Klebsiella oxytoca clinical isolate.
    Pérez-Llarena FJ; Fernández A; Zamorano L; Kerff F; Beceiro A; Aracil B; Cercenado E; Miro E; Oliver A; Oteo J; Navarro F; Bou G
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4540-3. PubMed ID: 22668859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of metallo-β-lactamase genes in clinically isolated Klebsiella pneumoniae and Klebsiella oxytoca.
    Tateno H; Yasuhara T; Sugano E; Tahara S; Ugajin K; Fukuchi K
    Rinsho Byori; 2014 Dec; 62(12):1191-6. PubMed ID: 25823233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nationwide study of mechanisms conferring reduced susceptibility to extended-spectrum cephalosporins in clinical Escherichia coli and Klebsiella spp. isolates.
    Tofteland S; Dahl KH; Aasnæs B; Sundsfjord A; Naseer U
    Scand J Infect Dis; 2012 Dec; 44(12):927-33. PubMed ID: 22991975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular identification of CTX-M and blaOXY/K1 beta-lactamase genes in Enterobacteriaceae by sequencing of universal M13-sequence tagged PCR-amplicons.
    Monstein HJ; Tärnberg M; Nilsson LE
    BMC Infect Dis; 2009 Jan; 9():7. PubMed ID: 19161622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceftazidime-hydrolysing β-lactamase OXA-145 with impaired hydrolysis of penicillins in Pseudomonas aeruginosa.
    Hocquet D; Colomb M; Dehecq B; Belmonte O; Courvalin P; Plésiat P; Meziane-Cherif D
    J Antimicrob Chemother; 2011 Aug; 66(8):1745-50. PubMed ID: 21665906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a blaVIM-4 gene in the internationally successful Klebsiella pneumoniae ST11 clone and in a Klebsiella oxytoca strain in Hungary.
    Kristóf K; Tóth A; Damjanova I; Jánvári L; Konkoly-Thege M; Kocsis B; Koncan R; Cornaglia G; Szego E; Nagy K; Szabó D
    J Antimicrob Chemother; 2010 Jun; 65(6):1303-5. PubMed ID: 20410063
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.